US Patent Issued to BIOSEUTICA on July 28 for "Ovotransferrins for use in the treatment of iron deficiency anaemia" (Italian Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,144, issued on July 28, was assigned to BIOSEUTICA B.V. (Zeewolde, Netherlands).

"Ovotransferrins for use in the treatment of iron deficiency anaemia" was invented by Valerio Maria Ferrari (Milan), Maria Carla Baggio (Saronno, Italy) and Paride Grisenti (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iro...